Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04095143 · ClinicalTrials.gov registry record
Ultrasound Markers of Organ Congestion in Severe Acute Kidney Injury
A clinical trial of Acute Kidney Injury and Fluid Overload, sponsored by Centre hospitalier de l'Université de Montréal (CHUM).
- Completed
- Registry status
- 125
- Enrollment target
- 6
- Study locations
NCT04095143 is a study of Acute Kidney Injury and Fluid Overload that has completed, run by Centre hospitalier de l'Université de Montréal (CHUM). The registered enrollment target is 125 participants, below the 2,329-participant average among 74 other Acute Kidney Injury trials with a reported enrollment target (95% lower). The trial reports 6 study locations across 4 states.
The verdict
NCT04095143, a study of Acute Kidney Injury and Fluid Overload, has completed, sponsored by Centre hospitalier de l'Université de Montréal (CHUM).
- COMPLETED
- Registry status
- 125 participants
- Enrollment target
- 6
- Study locations
Study Summary
Fluid overload is associated with adverse outcomes in patients with severe acute kidney injury. It remains unclear if fluid overload is merely a marker of disease severity or if organ congestion is a mediator of complications. Point-of-care ultrasound could be a modality used to assess organ congestion and its clinical implications. The objective of this study is to determine whether ultrasound markers of organ congestion are associated with major adverse kidney events in critically ill patients with severe acute kidney injury.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Portal vein flow
- DIAGNOSTIC_TEST Intra-renal flow
- DIAGNOSTIC_TEST Hepatic vein flow
- DIAGNOSTIC_TEST Pulmonary B-lines
- DIAGNOSTIC_TEST Dimensions of the inferior vena cava
Study Locations (6)
Ontario
- Sunnybrook Health Science Centre - Toronto
- St. Michael's hospital - Toronto
Quebec
- Centre Hospitalier de l'Université de Montréal - Montreal
- Montreal Heart Institute - Montreal
Kentucky
- University of Kentucky - Lexington
Alberta
- University of Alberta - Edmonton
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 125 participants |
| Start Date | 2018-09-04 |
| Est. Completion | 2022-09-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04095143
The ClinicalTrials.gov registry entry for NCT04095143 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 125 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,329-participant average among 74 other Acute Kidney Injury trials with a reported enrollment target (95% lower). The listed sponsor is Centre hospitalier de l'Université de Montréal (CHUM), which has 10 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Acute Kidney Injury appearing as the primary indexed condition, and to 5 interventions - of which Portal vein flow is the first listed.
NCT04095143 reports 6 study locations spanning 4 distinct geographic areas - top geographies include Ontario, Quebec, Kentucky.
Frequently Asked Questions
What is clinical trial NCT04095143 about?
NCT04095143 is a clinical study titled "Ultrasound Markers of Organ Congestion in Severe Acute Kidney Injury". Fluid overload is associated with adverse outcomes in patients with severe acute kidney injury. It remains unclear if fluid overload is merely a marker of disease severity or if organ congestion is a mediator of complications. Point-of-care ultrasound could be a modality used to assess organ congest...
What is the current status of trial NCT04095143?
This trial is currently completed. The enrollment target is 125 participants. The study started on 2018-09-04. Estimated completion is 2022-09-01.
What conditions does trial NCT04095143 study?
This clinical trial studies the following conditions: Acute Kidney Injury, Fluid Overload, Ultrasonography.
What interventions are being tested in trial NCT04095143?
The interventions under investigation include: Portal vein flow (DIAGNOSTIC_TEST), Intra-renal flow (DIAGNOSTIC_TEST), Hepatic vein flow (DIAGNOSTIC_TEST), Pulmonary B-lines (DIAGNOSTIC_TEST), Dimensions of the inferior vena cava (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04095143?
This trial is sponsored by Centre hospitalier de l'Université de Montréal (CHUM), which has 10 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04095143 being conducted?
This trial has 6 study locations across Kentucky, Alberta, Ontario, Quebec. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Acute Kidney Injury
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Ultra-Low Contrast Angiography in AKI
RECRUITING · Phase 3
-
Novel Treatments in Improving Renal Outcomes in Light Chain Cast Nephropathy
RECRUITING
-
Physiologic Signals and Signatures With the Accuryn Monitoring System - The Accuryn Registry
RECRUITING
-
Droxidopa to Increase Mean Arterial Pressure in Decompensated Cirrhosis Patients With Acute Kidney Injury
RECRUITING · Phase 2
-
Theophylline Prophylaxis During Hypothermia to Limit Neonatal Nephron Damage
RECRUITING · Phase 1
-
Groundbreaking Renal Assist Device Intervening to ENhance cardioThoracic Surgery Outcomes
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.